Find clinical trials for Endometrial Cancer in Paris, Île-de-France
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near Paris, Île-de-France, FRA:
The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...
Phase 2, Phase 3
Villejuif, France and 13 other locations
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Paris, France and 65 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Paris, France and 223 other locations
study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...
Phase 3
Paris, France and 94 other locations
The RAINBO program is a studies group which proposes personalized treatment of patients suffering from endometrial cancer according...
Phase 3
Paris, France and 14 other locations
non-resectable metastatic or locally advanced non-colorectal and non-endometrial cancers compared to the standard of care chemother...
Phase 2
Paris, Île-de-France, France and 21 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Paris, France and 168 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Paris, France and 73 other locations
This interventional study will evaluate the efficacy and safety of ART0380 as monotherapy in patients whose tumors have a biology to predict...
Phase 2
Paris, NAP, France and 14 other locations
A first-in-human study using BDC-1001 as a single agent and in combination with nivolumab in HER2 expressing advanced malignancies
Phase 1, Phase 2
Villejuif, France and 20 other locations
Clinical trials
Research sites
Resources
Legal